A detailed history of Israel Englander (Millennium Management LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 70,811 shares of HRMY stock, worth $2.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,811
Previous 307,420 76.97%
Holding current value
$2.32 Million
Previous $9.27 Million 69.51%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$30.0 - $39.95 $7.1 Million - $9.45 Million
-236,609 Reduced 76.97%
70,811 $2.83 Million
Q2 2024

Aug 14, 2024

BUY
$28.81 - $33.01 $3.02 Million - $3.46 Million
104,691 Added 51.64%
307,420 $9.27 Million
Q1 2024

May 15, 2024

BUY
$29.93 - $35.06 $5.4 Million - $6.32 Million
180,294 Added 803.63%
202,729 $6.81 Million
Q4 2023

Feb 14, 2024

SELL
$19.2 - $33.78 $8.95 Million - $15.7 Million
-465,965 Reduced 95.41%
22,435 $724,000
Q2 2023

Aug 14, 2023

BUY
$30.5 - $37.4 $1.38 Million - $1.7 Million
45,368 Added 10.24%
488,400 $17.2 Million
Q1 2023

May 15, 2023

BUY
$30.8 - $53.92 $8.32 Million - $14.6 Million
270,102 Added 156.19%
443,032 $14.5 Million
Q4 2022

Feb 14, 2023

BUY
$45.4 - $60.91 $6.58 Million - $8.83 Million
144,976 Added 518.62%
172,930 $9.53 Million
Q3 2022

Nov 14, 2022

BUY
$42.06 - $55.45 $1.18 Million - $1.55 Million
27,954 New
27,954 $1.24 Million
Q2 2022

Aug 15, 2022

SELL
$33.54 - $52.15 $492,467 - $765,718
-14,683 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$33.14 - $51.13 $144,291 - $222,620
4,354 Added 42.15%
14,683 $714,000
Q4 2021

Feb 14, 2022

SELL
$34.09 - $43.91 $1.48 Million - $1.9 Million
-43,333 Reduced 80.75%
10,329 $440,000
Q3 2021

Nov 15, 2021

SELL
$25.68 - $38.61 $2.45 Million - $3.68 Million
-95,261 Reduced 63.97%
53,662 $2.06 Million
Q2 2021

Aug 16, 2021

BUY
$25.96 - $33.44 $3.67 Million - $4.72 Million
141,270 Added 1845.94%
148,923 $4.2 Million
Q1 2021

May 17, 2021

SELL
$27.56 - $40.37 $3.78 Million - $5.53 Million
-137,010 Reduced 94.71%
7,653 $253,000
Q4 2020

Feb 16, 2021

SELL
$31.74 - $51.34 $8.56 Million - $13.8 Million
-269,624 Reduced 65.08%
144,663 $5.23 Million
Q3 2020

Nov 16, 2020

BUY
$30.96 - $44.39 $12.8 Million - $18.4 Million
414,287 New
414,287 $14 Million

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.94B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.